|AMERICAN COLLEGE OF MEDICAL GENETICS|
Standards and Guidelines for Clinical Genetics Laboratories
This updated edition of the STANDARDS AND GUIDELINES FOR CLINICAL GENETICS LABORATORIES is available at no charge. Drafts of revised and new sections are made available to members only for comment prior to being finalized by the Laboratory Quality Assurance Committee for submission to the Board of Directors for approval and incorporation into the posted document.
PRINTING PAGES: Set your printer left/right margins to 0.25" by clicking the "File" dropdown menu in your browser, and selecting the "Page Setup" item.
|GENERAL STANDARDS AND GUIDELINES|
|B: Personnel Policies|
|C: General Policies|
|D: Shared Methodologies|
|E: Clinical Cytogenetics|
|F: Clinical Biochemical Genetics|
|G: Clinical Molecular Genetics|
H: Prenatal Genetic Screening with Alphafetoprotein (AFP) and Related Analytes|
[See ONTD and DS (under Disease/Phenotype-Specific Standards and Guidelines below).
These two documents replace Section H.]
|DISEASE/PHENOTYPE-SPECIFIC STANDARDS AND GUIDELINES|
|CF: CFTR Mutation Testing.|
CF3: Cystic Fibrosis Carrier Screening, Laboratory Standards and Guidelines for Population-based|
(See CFTR Mutation Testing, above, for further information and updates.)
|DS: Prenatal Screening for Down Syndrome|
|FV/PT: Venous Thromboembolism (Factor V Leiden and Prothrombin 20210G>A Testing).|
|FX: Fragile X.|
|HD: Huntington Disease.|
|ONTD: Open Neural Tube Defects.|
|URD: Ultra-Rare Disorders.|